(Reuters) – Inovio Pharmaceuticals Inc said on Tuesday that Thermo Fisher Scientific would manufacture its experimental coronavirus vaccine to boost the supply of the vaccine.
The U.S-based drug developer said it plans to have 100 million doses of its vaccine in 2021 through its third-party manufacturers.
(Reporting by Manas Mishra in Bengaluru; Editing by Shailesh Kuber)
